Leveraging the Heterogeneity of Adaptative Immune cells Within the Tumor-Ecosystem to Better Describe Clear Cell Renal Cell Carcinoma Biologically and Clinically – Beyond the Abstract

Previous
Previous

Dr. Ferrall-Fairbanks and the BEAT Cancer Lab highlighted in 2022 CrossLink on Cancer

Next
Next

Rules of Engagement: The Lymphocyte Receptor Ecosystem in Renal Cell Carcinoma